[HTML][HTML] Editor's choice--European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral …

J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024 - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

[HTML][HTML] A framework for perioperative care for lower extremity vascular bypasses: A Consensus Statement by the Enhanced Recovery after Surgery (ERAS®) Society …

KL McGinigle, EL Spangler, K Ayyash, AK Vavra… - Journal of Vascular …, 2023 - Elsevier
Abstract The Society for Vascular Surgery and the Enhanced Recovery After Surgery
(ERAS) Society formally collaborated and elected an international, multi-disciplinary panel …

Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances

S Carlin, TAC de Vries, A Budaj… - … Polska (Polish Heart …, 2022 - journals.viamedica.pl
Atherosclerotic cardiovascular disease (ASCVD), which includes coronary artery disease
(CAD), cerebrovascular disease, and peripheral arterial disease (PAD) is associated with …

[HTML][HTML] Editor's Choice–European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases

CP Twine, SK Kakkos, V Aboyans… - European Journal of …, 2023 - Elsevier
1.1. Purpose The European Society for Vascular Surgery (ESVS) has developed a series of
clinical practice guidelines for clinicians caring for patients with vascular diseases. This is …

Rivaroxaban plus aspirin versus aspirin alone after endovascular revascularization for symptomatic PAD: insights from VOYAGER PAD

J Rymer, SS Anand, E Sebastian Debus, LP Haskell… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Rivaroxaban plus aspirin compared with aspirin alone reduced major
cardiac and ischemic limb events after lower extremity revascularization (LER) in the …

[HTML][HTML] Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits

N Govsyeyev, M Nehler, MS Conte, S Debus… - Journal of Vascular …, 2023 - Elsevier
Background Patients with peripheral artery disease (PAD) requiring lower extremity
revascularization (LER) have a high risk of adverse limb and cardiovascular events. The …

[HTML][HTML] Management of peripheral arterial disease: lifestyle modifications and medical therapies

RW King, ME Canonico, MP Bonaca… - Journal of the Society for …, 2022 - Elsevier
Peripheral artery disease (PAD) commonly refers to atherosclerotic narrowing of
noncoronary arteries, primarily those supplying the lower extremities. The risk factors for …

Optimal conduit choice for open lower extremity bypass in chronic limb-threatening ischemia

JP Thomas, KL So, JT Turner, AJ Malanowski… - Seminars in vascular …, 2022 - Elsevier
Open bypass surgery remains a major tool for limb salvage in chronic limb-threatening
ischemia (CLTI). Although rest pain and tissue loss both fall into the category of CLTI, goals …

[HTML][HTML] Optimization of the pharmacological therapy in patients with poly-vascular disease: a multidisciplinary approach

R Gioscia, C Castagno, M Verdoia, B Conti… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The recent shift of the concept of cardiovascular disease as a chronic progressive condition,
potentially involving multiple districts, has driven attention to the optimal management of …

Cardiovascular Prognosis in Patients with Peripheral Artery Disease and Approach to Therapy

A Curcio, A Panarello, C Spaccarotella, C Indolfi - Biomedicines, 2023 - mdpi.com
Peripheral artery disease (PAD), the pathophysiologic narrowing of the arterial blood
vessels of the lower limbs due to atherosclerosis, is estimated to affect more than 200 million …